Results 321 to 330 of about 6,410,935 (343)

Experimental Approaches Toward Histone Acetyltransferase Modulators as Therapeutics

Medical Epigenetics, 2021
exaly  

Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide.

Antiviral Research, 2012
Min Qiu, Yu Chen, Siwei Song, Hong-yong Song, Ying Chu, Zhongping Yuan, Lin Cheng, Da-Tong Zheng, Zhi-Wei Chen, Zhi-Wei Wu   +9 more
semanticscholar   +1 more source

Few Physicians Prescribe 5-Alpha Reductase Inhibitors for Prostate Cancer Prevention

Ca-A Cancer Journal for Clinicians, 2011
Mary Kay Barton
exaly  

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.

Biochemical Pharmacology, 2012
R. Mosi, Virginia Anastassova, Jennifer Cox, M. Darkes, Stefan R Idzan, J. Labrecque, Gloria H Y Lau, Kim L. Nelson, K. Patel, Zefferino Santucci, R. Wong, R. Skerlj, G. Bridger, D. Huskens, D. Schols, S. Fricker   +15 more
semanticscholar   +1 more source

Outcome of Combining Epigenetic Drugs With Other Treatments in the Clinic

Medical Epigenetics, 2016
Paromita Raha
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2016
exaly  

HIV entry inhibitors

The Biomedical & Life Sciences Collection, 2011
openaire   +1 more source

HIV Entry Inhibitors and Their Potential in HIV Therapy

Medicinal Research Reviews, 2009
Kuo-Hsiung Lee, Keduo Qian
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'Regan, R M O'Regan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2016
exaly